Linezolid Kabi

Linezolid, the active ingredient in Linezolid Kabi, is an oxazolidinone presented as an injection for intravenous use. It treats serious bacterial infections such as complicated skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and infections caused by MRSA or VRE in adult patients. GNH USA supplies Linezolid Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibacterial indicated for several serious infections. - Complicated skin and soft tissue infections: provides bactericidal activity against susceptible Gram‑positive pathogens, facilitating recovery. - Community‑acquired pneumonia: treats pneumonia caused by susceptible organisms, improving respiratory function. - Nosocomial pneumonia: effective against hospital‑acquired respiratory infections, reducing morbidity. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: offers an alternative to vancomycin for resistant strains. - Vancomycin‑resistant Enterococcus (VRE) infections: active against resistant enterococci where other options are limited.

Adverse reactions may occur with linezolid therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Rash: skin erythema or pruritus. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: nerve damage presenting as tingling or numbness. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuropathy: vision changes that may be irreversible.

Use linezolid with careful clinical monitoring. - Renal impairment: assess renal function and monitor for accumulation. - Hepatic dysfunction: evaluate liver enzymes regularly. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Prolonged therapy: perform routine blood‑count surveillance. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid may interact with several drug classes.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity. - Tricyclic antidepressants: additive serotonergic effect.

Moderate Interactions (Monitor Closely): - Rifampin: induces metabolism, reducing linezolid exposure. - Warfarin: may increase INR, requiring coagulation monitoring. - Anticonvulsants (e.g., carbamazepine): may lower linezolid concentrations.